Cellectis SA (CLLS)
3.50
-0.02
(-0.57%)
USD |
NASDAQ |
May 22, 16:00
3.54
+0.04
(+1.14%)
After-Hours: 20:00
Cellectis EPS Diluted (Quarterly) : -0.1774 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| DBV Technologies SA | -0.5577 |
| Akari Therapeutics Plc | -9.584 |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -1.28 |
| Autolus Therapeutics Plc | -0.2686 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.83M |
| Revenue (Quarterly) | 5.798M |
| Total Expenses (Quarterly) | 23.63M |
| Enterprise Value | 275.08M |
| Gross Profit Margin (Quarterly) | 21.50% |
| Profit Margin (Quarterly) | -307.5% |
| Earnings Yield | -19.24% |
| Normalized Earnings Yield | -17.26 |